Chesley Taft & Associates LLC Novartis Ag Transaction History
Chesley Taft & Associates LLC
- $2.05 Billion
- Q1 2025
A detailed history of Chesley Taft & Associates LLC transactions in Novartis Ag stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 32,147 shares of NVS stock, worth $3.56 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
32,147
Previous 32,347
0.62%
Holding current value
$3.56 Million
Previous $3.15 Million
13.85%
% of portfolio
0.18%
Previous 0.15%
Shares
31 transactions
Others Institutions Holding NVS
# of Institutions
1,492Shares Held
131MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.35 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.22 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$907 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$762 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$618 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $238B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...